Xilio Therapeutics, Inc. (NASDAQ: XLO)
| Pre-Market |
Intra-Day |
After-Hours |
| - (- / -%) |
8.57 (0.22 / 2.63%) |
8.74 (0.17 / 1.98%) |
| - |
17-Apr 16:00 |
17-Apr 17:52 |
Sector:
Healthcare || Industry:
Biotechnology
| Previous Close |
8.35 |
Year Low |
6.47 |
| Open |
8.61 |
Year High |
16.52 |
| Day Low |
8.31 |
Price Avg 50 |
7.92 |
| Day High |
8.76 |
Price Avg 200 |
9.53 |
| Volume |
38.16 K |
Market Cap |
49.56 M |
News
Analysis
| XLO |
2.63 |
0.59 |
15.34 |
-4.35 |
-17.60 |
-18.54 |
Earnings
| 03/23/2026 |
BMO |
XLO |
Xilio Therapeutics |
Q4 2025 |
EPS |
-0.12 |
0.81 |
775.00 |
-0.20 |
|
|
| 03/23/2026 |
BMO |
XLO |
Xilio Therapeutics |
Q4 2025 |
REV |
7.96 M |
13.69 M |
71.93 |
1.72 M |
695.70 |
|
| 11/13/2025 |
BMO |
XLO |
Xilio Therapeutics |
Q3 2025 |
EPS |
-0.03 |
-0.11 |
-266.67 |
-0.22 |
50.00 |
|
| 11/13/2025 |
BMO |
XLO |
Xilio Therapeutics |
Q3 2025 |
REV |
18.64 M |
19.07 M |
2.31 |
2.26 M |
742.51 |
|
| 08/14/2025 |
BMO |
XLO |
Xilio Therapeutics |
Q2 2025 |
EPS |
-0.08 |
-0.16 |
-100.00 |
-0.24 |
33.30 |
|
| 08/14/2025 |
BMO |
XLO |
Xilio Therapeutics |
Q2 2025 |
REV |
8.21 M |
8.08 M |
-1.53 |
2.36 M |
242.98 |
|
| 05/08/2025 |
BMO |
XLO |
Xilio Therapeutics |
Q1 2025 |
EPS |
-0.16 |
-0.18 |
-12.50 |
-0.59 |
69.50 |
Healthcare / Biotechnology |
| 05/08/2025 |
BMO |
XLO |
Xilio Therapeutics |
Q1 2025 |
REV |
7.40 M |
2.93 M |
-60.41 |
|
0.00 |
Healthcare / Biotechnology |
Outlooks
* Growth at Outlook Mid-point against Estimate
Ratings
Dividends
Sign-Up to see the full list of CATALYSTS in the Calendars
<<Back to Stock Screener>>